Literature DB >> 11547114

Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux.

R H Thompson1, J J Chen, J Pugach, S Naseer, G F Steinhardt.   

Abstract

PURPOSE: We reviewed our experience with patients with vesicoureteral reflux treated off prophylactic antibiotics.
MATERIALS AND METHODS: We retrospectively reviewed the records of patients with vesicoureteral reflux treated off prophylactic antibiotics, noting the intervals on and off antibiotics, urinary tract infection, signs and symptoms associated with urinary tract infection, and renal ultrasound and dimercapto-succinic acid scan findings.
RESULTS: We identified 196 patients with vesicoureteral reflux treated off prophylactic antibiotics, including 122 who were infection-free while on and 124 who had no urinary tract infection while off prophylactic antibiotics. The infection rate on and off prophylactics was 0.29 and 0.24 urinary tract infections per patient per year, respectively. New scars were identified in 5 patients while on prophylactics and in 7 after antibiotics were discontinued. Comparing different subgroups off prophylactic antibiotics showed that children who presented with scarring had statistically fewer new scars than those with normal initial dimercapto-succinic acid imaging (p <0.043). Girls had significantly more urinary tract infections than boys while off prophylactics (p <0.01) despite the older age at antibiotic cessation. However, after infection occurred while off prophylactic antibiotics, new renal scars developed at about the same rate in boys and girls. Because most patients did not have a urinary tract infection while off prophylactic antibiotics, new renal scars developed in only 2.2% of all boys and 4% of all girls.
CONCLUSIONS: Our findings imply that discontinuing antibiotics is reasonable and safe in patients in whom vesicoureteral reflux fails to resolve.

Entities:  

Mesh:

Year:  2001        PMID: 11547114

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Mild antenatal hydronephrosis: management controversies.

Authors:  Laura Alconcher; Marcela Tombesi
Journal:  Pediatr Nephrol       Date:  2004-05-01       Impact factor: 3.714

2.  Medical versus surgical management for vesicoureteric reflux: the case for medical management.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

3.  The efficacy of digital fluoroscopic image capture in the evaluation of vesicoureteral reflux in children.

Authors:  Nancy R Fefferman; Amy S Sabach; Rafael Rivera; Sarah Milla; Lynne P Pinkney; Naomi A Strubel; James Babb
Journal:  Pediatr Radiol       Date:  2009-08-29

4.  Probiotics prophylaxis in infants with primary vesicoureteral reflux.

Authors:  Seung Joo Lee; Jung Won Lee
Journal:  Pediatr Nephrol       Date:  2014-10-30       Impact factor: 3.714

Review 5.  Relevance of current guidelines in the management of VUR.

Authors:  Alexander Springer; Ramnath Subramaniam
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

Review 6.  Diagnosis and management of vesicoureteral reflux in children.

Authors:  Christopher S Cooper
Journal:  Nat Rev Urol       Date:  2009-08-11       Impact factor: 14.432

Review 7.  May we go on with antibacterial prophylaxis for urinary tract infections?

Authors:  R Beetz
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 8.  Applying the ALARA concept to the evaluation of vesicoureteric reflux.

Authors:  Richard S Lee; David A Diamond; Jeanne S Chow
Journal:  Pediatr Radiol       Date:  2006-09

9.  The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol.

Authors:  Sumit Dave; Antoine E Khoury
Journal:  Indian J Urol       Date:  2007-10

10.  Treatment of vesicoureteral reflux after puberty.

Authors:  J Christopher Austin
Journal:  Adv Urol       Date:  2009-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.